RR

Rekha Raina

Active Director Director DIN 10240023
DIN 10240023 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Rekha Raina

Data last updated:

Rekha Raina is a Director at Gasch Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Gasch Pharmaceuticals Private Limited reported revenue of ₹16,519 (FY 2024).

DIN 10240023
Primary Designation Director
Industry Pharma
First Appointment 14 Jul 2023
Oldest Company Age 3 yrs
Largest company Gasch Pharmaceuticals Private Limited · ₹16,519 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jul 20232023₹16,519 (FY 2024)Active

Board colleagues of Rekha Raina

NameDINCompanyDesignation
Verinder Mohan Raina10240022Gasch Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gasch Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rekha Raina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Raina

Rekha Raina currently holds 1 directorship: Gasch Pharmaceuticals Private Limited (Director, since 14 Jul 2023, revenue ₹16,519 (FY 2024)).

Rekha Raina was first appointed on 14 Jul 2023 as Director at Gasch Pharmaceuticals Private Limited.

The current boards of Rekha Raina's companies include Verinder Mohan Raina (Gasch Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available